All In Biotech

Drug Trial Radar · NCT07136805

A Phase 3 Study of VVN461 Ophthalmic Solution for Noninfectious Anterior Uveitis

A Multi-center, Randomized, Single-masked, Active-controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of 1.0% VVN461 Ophthalmic Solution in Patients With Non-infectious Anterior Uveitis

Last checked: Nov 20, 2026Latest source record: Aug 24, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 154 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

154

Actual

Start

Nov 25, 2025

Primary completion

Dec 31, 2026

Study completion Apr 30, 2027

Sponsor

Lead sponsor
VivaVision Biotech, IncIndustry
Sponsor type
Industry
First posted
Aug 22, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multicenter, randomized, single-masked, active-controlled, parallel, Phase III pivotal study in China

Conditions

  • Non-infectious Anterior Uveitis

Interventions

  • VVN461 Ophthalmic Solution 1.0%Drug

    1 drop for study eye each time, 6 times daily (Q2h) for 7 days; 4 times daily (QID) for 7 days; 2 times daily (BID) for 7 days; 1 time daily for 7 days

  • 1.0% prednisolone acetateDrug

    1 drop for study eye each time, 6 times daily (Q2h) for 7 days; 4 times daily (QID) for 7 days; 2 times daily (BID) for 7 days; 1 time daily for 7 days

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline in anterior chamber cell (ACC) grade in the study eye at Day 14Time frame: Day 14

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Peking University First Hospital

    Beijing, China

  • The First Affiliated Hospital of Chongqing Medical University

    Chongqing, Chongqing Municipality, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.